Log in

NASDAQ:QTRX - Quanterix Stock Price, Forecast & News

$17.07
+0.80 (+4.92 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
$15.13
Now: $17.07
$17.67
50-Day Range
$11.17
MA: $22.27
$28.72
52-Week Range
$10.90
Now: $17.07
$36.15
Volume173,455 shs
Average Volume208,901 shs
Market Capitalization$481.89 million
P/E RatioN/A
Dividend YieldN/A
Beta1.38
Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Simoa HD-1 instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also develops SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sell its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Lexington, Massachusetts.
Read More
Quanterix logo

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:QTRX
CUSIPN/A
Phone617-301-9400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$56.73 million
Book Value$4.59 per share

Profitability

Net Income$-40,800,000.00

Miscellaneous

Employees177
Market Cap$481.89 million
Next Earnings Date5/8/2020 (Estimated)
OptionableNot Optionable

Receive QTRX News and Ratings via Email

Sign-up to receive the latest news and ratings for QTRX and its competitors with MarketBeat's FREE daily newsletter.


Quanterix (NASDAQ:QTRX) Frequently Asked Questions

How has Quanterix's stock been impacted by COVID-19 (Coronavirus)?

Quanterix's stock was trading at $18.51 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, QTRX stock has decreased by 7.8% and is now trading at $17.07. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Quanterix?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quanterix in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Quanterix.

When is Quanterix's next earnings date?

Quanterix is scheduled to release its next quarterly earnings announcement on Friday, May 8th 2020. View our earnings forecast for Quanterix.

What price target have analysts set for QTRX?

2 brokers have issued 1 year price targets for Quanterix's stock. Their forecasts range from $32.00 to $35.00. On average, they anticipate Quanterix's stock price to reach $33.50 in the next year. This suggests a possible upside of 96.3% from the stock's current price. View analysts' price targets for Quanterix.

Has Quanterix been receiving favorable news coverage?

Press coverage about QTRX stock has trended very positive on Saturday, according to InfoTrie Sentiment. The research firm scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Quanterix earned a coverage optimism score of 3.1 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. View the latest news aboutQuanterix.

Are investors shorting Quanterix?

Quanterix saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 1,439,700 shares, an increase of 16.1% from the February 27th total of 1,240,000 shares. Based on an average trading volume of 161,200 shares, the short-interest ratio is currently 8.9 days. Approximately 7.4% of the shares of the stock are sold short. View Quanterix's Current Options Chain.

Who are some of Quanterix's key competitors?

What other stocks do shareholders of Quanterix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Quanterix investors own include InVitae (NVTA), Allena Pharmaceuticals (ALNA), Crispr Therapeutics (CRSP), Spero Therapeutics (SPRO), Veracyte (VCYT), KeyCorp (KEY), Akoustis Technologies (AKTS), Advanced Micro Devices (AMD), Ardelyx (ARDX) and Cara Therapeutics (CARA).

Who are Quanterix's key executives?

Quanterix's management team includes the following people:
  • Mr. E. Kevin Hrusovsky, Chairman, Pres & CEO (Age 58)
  • Dr. David R. Walt, Co-Founder, Chairman of Scientific Advisory Board & Director (Age 66)
  • Dr. David C. Duffy Ph.D., Sr. VP of R&D and CTO (Age 48)
  • Mr. Amol Chaubal, Chief Financial Officer (Age 43)
  • Mr. Bruce J. Bal, VP of Operations, Service & Quality (Age 60)

When did Quanterix IPO?

(QTRX) raised $50 million in an IPO on Thursday, December 7th 2017. The company issued 3,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morga and Leerink Partners acted as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

What is Quanterix's stock symbol?

Quanterix trades on the NASDAQ under the ticker symbol "QTRX."

Who are Quanterix's major shareholders?

Quanterix's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Macquarie Group Ltd. (4.78%), Macquarie Group Ltd. (4.74%), FMR LLC (3.17%), Royce & Associates LP (1.86%), State Street Corp (0.86%) and Bank of New York Mellon Corp (0.74%). Company insiders that own Quanterix stock include David C Duffy, David R Walt, Dawn Mattoon, E Kevin Hrusovsky, Ernest Orticerio, John M Connolly, Joseph Driscoll, Marijn E Dekkers, Mark T Roskey and Martin D Madaus. View institutional ownership trends for Quanterix.

Which institutional investors are selling Quanterix stock?

QTRX stock was sold by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, Barclays PLC, Credit Suisse AG, Bank of America Corp DE, Advisory Research Inc., AQR Capital Management LLC, Carnegie Capital Asset Management LLC, and Geode Capital Management LLC. Company insiders that have sold Quanterix company stock in the last year include David C Duffy, Dawn Mattoon, E Kevin Hrusovsky, Marijn E Dekkers, Mark T Roskey, and Martin D Madaus. View insider buying and selling activity for Quanterix.

Which institutional investors are buying Quanterix stock?

QTRX stock was acquired by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Macquarie Group Ltd., FMR LLC, Kornitzer Capital Management Inc. KS, Bank of Montreal Can, State Street Corp, Platinum Investment Management Ltd., and Renaissance Technologies LLC. Company insiders that have bought Quanterix stock in the last two years include David R Walt, and John M Connolly. View insider buying and selling activity for Quanterix.

How do I buy shares of Quanterix?

Shares of QTRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Quanterix's stock price today?

One share of QTRX stock can currently be purchased for approximately $17.07.

How big of a company is Quanterix?

Quanterix has a market capitalization of $481.89 million and generates $56.73 million in revenue each year. The company earns $-40,800,000.00 in net income (profit) each year or ($1.63) on an earnings per share basis. Quanterix employs 177 workers across the globe. View additional information about Quanterix.

What is Quanterix's official website?

The official website for Quanterix is http://www.quanterix.com/.

How can I contact Quanterix?

Quanterix's mailing address is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. The company can be reached via phone at 617-301-9400.


MarketBeat Community Rating for Quanterix (NASDAQ QTRX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  232 (Vote Outperform)
Underperform Votes:  280 (Vote Underperform)
Total Votes:  512
MarketBeat's community ratings are surveys of what our community members think about Quanterix and other stocks. Vote "Outperform" if you believe QTRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QTRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel